PSMA, What It Is and Why It Matters to Prostate Cancer Patients

by | Jul 2, 2021 | 1 comment

Keith Crawford, MD, PhD
Director of Clinical Trials and Patient Education
PHEN
Discusses definitions and differences between PSA and PSMA

Michael J. Morris, MD
Medical Oncologist
MSKCC, Sydney Kimmel Center for Prostate Cancer
Discusses the successful VISION clinical trial.

Michael Groaning, PhD
Global Medical Affairs Lead
Amgen
Discusses Amgen’s AMG160 clinical trial.

1 Comment

  1. Matthew Abdullah
    Matthew Abdullah on December 8, 2021 at 11:51 AM

    I have just been diagnosed with stage 4 and I have not decided on any of the treatment options.
    I’m interested in participating in a clinical trial. Can you help me?

    Reply

Submit a Comment

Your email address will not be published. Required fields are marked *